Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesPayablesPrepaid AssetsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Cannabis Bioscience International Holdings (CBIH) Total Current Liabilities (2023 - 2026)

Cannabis Bioscience International Holdings' Total Current Liabilities history spans 4 years, with the latest figure at $1.2 million for Q1 2026.

  • On a quarterly basis, Total Current Liabilities rose 25.68% to $1.2 million in Q1 2026 year-over-year; TTM through Feb 2026 was $1.2 million, a 25.68% increase, with the full-year FY2025 number at $945963.0, up 7.26% from a year prior.
  • Total Current Liabilities hit $1.2 million in Q1 2026 for Cannabis Bioscience International Holdings, up from $1.1 million in the prior quarter.
  • Over the last five years, Total Current Liabilities for CBIH hit a ceiling of $1.2 million in Q1 2026 and a floor of $385547.0 in Q2 2023.
  • Historically, Total Current Liabilities has averaged $885479.5 across 4 years, with a median of $881909.0 in 2024.
  • Biggest five-year swings in Total Current Liabilities: surged 128.74% in 2024 and later increased 7.26% in 2025.
  • Tracing CBIH's Total Current Liabilities over 4 years: stood at $660307.0 in 2023, then soared by 32.16% to $872674.0 in 2024, then soared by 30.15% to $1.1 million in 2025, then increased by 7.34% to $1.2 million in 2026.
  • Business Quant data shows Total Current Liabilities for CBIH at $1.2 million in Q1 2026, $1.1 million in Q4 2025, and $1.0 million in Q3 2025.